Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia
ConclusionsErtapenem may be of comparable efficacy to class 2 carbapenems in the empirical treatment of 3GCRE bacteraemia.
Source: Journal of Antimicrobial Chemotherapy - Category: Microbiology Source Type: research
More News: Chemotherapy | Gastroenteritis | Microbiology | Respiratory Medicine | Septic Shock | Study | Thailand Health